Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet.

GSK has news on that front today, as well, reporting that the phase 2/3 COSTAR trial of Jemperli with experimental TIM-3 antagonist cobolimab will move into the phase 3 stage on the advice of its ...

GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax ... years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for Cambridge ...

In any case, today’s beta 3 updates bring us closer to that public launch, which should arrive some time in May. Since features in the coming software wave are minimal, we may see an especially ...

In between, we can expect two or three more beta builds. Apple also released iPadOS 18.5 Beta 3, watchOS 11.5 Beta 3, macOS Sequoia 15.5 Beta 3, macOS Sonoma 14.7.6 RC2, macOS Ventura 13.7.6 RC2, tvOS ...

Apple has officially released iOS 18.5 Beta 3, a significant update aimed at refining the overall user experience. This beta version, currently available to developers, focuses on targeted bug ...

Are you going to be a parent soon or planning your baby? Scroll down to check out some of the baby names that you can consider for your Gen Alpha and Gen Beta baby. Names significantly impact the ...

Maybe Siri will finally know when the full moon is? Probably not. Aside from the riveting release of iOS 18.5 beta 4, macOS Sequoia 15.5 beta 3, and iPadOS 18.5 beta 3, you’ll even find new beta ...

At first blush, an ETF with a dividend yield of 3.17% that has outperformed the iShares Core S&P 500 ETF (IVV) by around 9.3% this year thanks to its low beta and ... Seeking Alpha and the ETFs ...

Uniphar is one of several pharmaceutical companies at Citywest business park. Picture: Post Reporter ...

We’re only on beta 3 so far, which means Apple has time to still implement more changes. It’s also possible that some of the latest features won’t be revealed until Apple ships the software ...